NEW from Bright Spots: The Twenty-Year Road to Ending Cervical Cancer in China Hear from Professor & Director of Center for Global Health, You-lin Qiao, MD, PhD, and his team on their journey to launch an HPV vaccine campaign targeting adolescent girls in Ordos City, China. Learn how the succ...

Stories of Resourcefulness, Adaptability & Resilience View Stories In an ongoing effort to shine a light on voices of innovation...

Dear all  Greetings from KVG team and wish to share the following with the viewers for needful. Write-up As per World Health Organization (WHO) there is "no evidence" that the BCG vaccine protects against COVID-19. Initially, WHO also stated that there were no enough evidences of airborne tr...

Between 21 and 24 February 2017, the “Training for the comprehensive analysis of vaccination coverage surveys” was held in Kathmandu, Nepal. This training brought together 25 participants from Ministries of Health, National Statistics Offices (NSOs) and research institutes from Cambodia, China, Indo...

Background: Rabies is a dreaded disease and an estimated 55,000 people die of rabies every year. Himachal Pradesh is in the North bordering China and is predominantly rural and hilly. Villages are near forests, where wild reservoirs of rabies exist. Since health facilities are not accessible easily,...

Member States Delegates discuss progress towards global immunization goals at the World Health Assembly, May 2014 Fifty-four speakers including 50 representatives from Member States[1], one Observer[2], Civil Society Organizations[3] and the GAVI Alliance took the floor during the discussion on t...

Many thanks to Robert Davis for this lead! Recent Technical Updates POSSIBLE INTERRUPTION OF MEASLES VIRUS TRANSMISSION, UGANDA 2006-2009 Full text, with tables and figures, is at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204633/pdf/10-0753_finalD.pdf SINGLE ENDEMIC GENOTYPE OF MEAS...

Cross-posted from the January 2012 issue of GIN with thanks. 31/01/2012 from Madhav Balakrishnan, WHO HQ The Global Network for Post-marketing Surveillance (PMS) of Vaccines was established by WHO in early 2008 with a primary objective to monitor the safety of WHO prequalified vaccines supplied thr...

Here is a summary of interventions made by country delegations during the GVAP discussion at the WHO Executive Board on 21 January. - A number of delegations mentioned the importance of including measles elimination as part of the GVAP (there was some discussion as to whether it should be eradi...

While immunization partners involved in supporting vaccine supply chain (WHO, UNICEF’s CCL and Project Optimize ...) are collaborating and building on each others’ experiences, there are several pertinent questions to the field yet to be addressed: 1. Questions related to standby generators: Alt...

by Darin Zehrung, Jean-Marie Préaud, and Emily Griswold, PATH In an effort to advance the development of promising new rotavirus vaccine candidates, PATH is assisting manufacturers in Brazil, China, and India in the formulation, manufacturing, and clinical development of the vaccine candidates. T...

Dear Friends, More than 225 Rag pckers, Door to door garbage collectore and News paper howkers were administered FREE INTRADERMAL preventive vaccination ( Pre-prophylaxis) on World Rabies Day 2010 at State Intradermal antirabies Clinic and research centre, Shimla, Himachal Pradesh, India. ( Some P...

China considers VVMs by Qiyou Xiao, China National Biotec Group; Shuyan Zuo, WHO China; and Jack Zhang, PATH China In June, the first national seminar and information session about the necessity and feasibility of using vaccine vial monitors (VVMs) on domestically produced vaccines used in China w...

Vaccine vial monitor use, policy, and practices in four regionsby Julie Milstien, independent consultant While the benefits of using vaccine vial monitors (VVMs) in immunization programs are widely known, a recently completed study of VVM use and availability shows that their use is still not univer...

Dear Friends, Recently there have been a number of articles critical of the recommendations for pneumococcal and the pentavalent vaccines in high impact journals. I understand some of this has spilled over to the lay press and it will be good if we can have clarity on these issu...

POST 01391E: VACCINE-DERIVED POLIO VIRUS 18 FEBRUARY 2009 ****************************************** In the context of the discussions on polio eradication on our forum (see POSTS: 01354E), these reports hold great interest. Cross-posting yet again from CSU, with a big thank you to Bob D...

POST 01342E: POLIO ERADICATION VS CONTROL—THE DEBATE CONTINUES FOLLOW-UP ON POSTS 01339E & 01341E 27 OCTOBER 2008 ****************************************** The topic continues to be hotly debated and perspectives seem to differ widely. For those of you who would like a statistical u...

POST 01277E: VVM—A WHO-PREQUALIFIED AND VALIDATED TOOL FOLLOW-UP ON POSTS: 01264E, 01266E, 01275E 10 JUNE 2008 ******************************************* The query regarding VVM reliability has generated a fair number of responses--a few heated ones too. An interesting diversion here be...

POST 01158E : VACCINE OUT-OF-THE-COLD-CHAIN 17 September 2007 ________________________________________ The following article describes the use of an out-of-the-cold-chain immunization strategy to improve the timeliness of the HB birth dose in rural China. It showed a large improvement ...

Post 01049E : MEASLES GOAL AND RELATED MATERIAL 3 February 2007 ________________________________________ As many of you probably know already, WHO has announced officially on January 19, 2007, that the goal of measles mortality reduction by 2005 has been well achieved. We should all b...